The 6-Month Prognosis Rule Makes Hospice Eligibility a Guessing Game

Medicare requires that two physicians certify a patient has six months or less to live before they can enroll in hospice. The problem is that doctors are terrible at predicting death. Studies show that 13.4% of hospice patients survive more than six months after admission, and for patients with chronic diseases like Alzheimer's, COPD, and heart failure, the trajectory of decline is inherently unpredictable, with alternating episodes of deterioration and recovery that make six-month prognostication closer to coin-flipping than medical science. Why does this matter? It creates a two-sided failure. On one side, physicians who fear audit liability under-refer: they wait until patients are days from death before making the hospice referral, resulting in a median hospice stay of just 18 days when the benefit is designed for six months. On the other side, some hospices exploit the subjectivity by enrolling patients who are clearly not dying, recertifying them indefinitely to collect per-diem payments. Both failure modes stem from the same root cause: the rule demands a precision that medicine cannot deliver. This persists because the six-month rule is baked into the original 1982 Medicare Hospice Benefit statute. Changing it requires an act of Congress. CMS has tried to work around it with additional certification requirements and auditing, but the fundamental problem is that the eligibility criterion is a binary threshold imposed on a continuous and uncertain biological process. A JAMA study evaluating prognostic criteria for lung, heart, and liver disease found that the criteria identified patients with a six-month mortality rate of only 47% to 68%, meaning the rule misclassifies a third to half of patients.